Encompass Health (US:EHC) Globenewswireยท2025-10-09 16:46Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Encompass Health Corporation for possible violations of federal securities laws and unlawful business practices affecting stockholders [1][2]. Investigation Details - The investigation is prompted by allegations that Encompass's for-profit hospitals perform below average on key safety measures, as reported by The New York Times [6]. - Specific concerns include that Encompass owns facilities with significantly worse rates of potentially preventable readmissions, with 34 facilities rated poorly by Medicare [6]. Stock Impact - Following the publication of the allegations, Encompass's stock price dropped by $12.39, or 10.4%, closing at $107.28 per share on July 15, 2025, indicating a direct financial impact on investors [6].